Showing 1991-2000 of 3314 results for "".
- Visus Therapeutics Announces Executive Leadership Appointments in Operations, Research, Clinical Operations and Intellectual Propertyhttps://modernod.com/news/visus-therapeutics-announces-executive-leadership-appointments-in-operations-research-clinical-operations-and-intellectual-property/2479290/Visus Therapeutics announced the appointment of six new senior leaders, including Tim Grinstead as Chief Operating Officer; James Burke as Vice President of Research; Patrick Hughes, PhD, as Vice President of Pharmaceutical Development; Lisa Simpson as Vice President of Clinical Operations and Co
- Oyster Point Announces Preclinical Study Results and Pipeline Expansion With ETF Gene Therapy for Ocular Surface Diseaseshttps://modernod.com/news/oyster-point-announces-preclinical-study-results-and-pipeline-expansion-with-etf-gene-therapy-for-ocular-surface-diseases/2479258/Oyster Point Pharma announced the expansion of its pipeline with the introduction of Enriched Tear Film (ETF) Gene Therapy and proof-of-concept in vivo study results from its first gene therapy candidate, OC-101. ETF Gene Therapy is a proprietary adeno-associated virus (AAV) based
- CooperVision DreamLite Ortho-K Lenses Gain European Approval for Slowing Progression of Myopiahttps://modernod.com/news/coopervision-dreamlite-ortho-k-lenses-gain-european-approval-for-slowing-progression-of-myopia/2479240/CooperVision Specialty EyeCare’s Procornea DreamLite night lenses have received European approval for slowing the progression of myopia in children and young adults. The orthokeratology contact lens is the latest CooperVision myopia control product to gain the CE Mark, joining EyeDream and Parago
- Why Can’t Americans Buy Contact Lenses From Vending Machines?https://modernod.com/news/why-cant-americans-buy-contact-lenses-from-vending-machines/2479238/A recent report in The Federalist details the ability to purchase contact lenses throughout most of Europe versus the United States, and the role regulatory agencies have in wh
- Okayama University Research: High Levels of Television Exposure Affect Visual Acuity in Childrenhttps://modernod.com/news/okayama-university-research-high-levels-of-television-exposure-affect-visual-acuity-in-children/2479236/In a study reported in the Japanese Journal of Ophthalmology, researchers from Okayama University show that long hours in front of the television in children under 3 years of age lead to increased eyesight concerns during later years. It is ingrained in parents to curtail the hours
- Essilor Receives FDA Breakthrough Device Designation for Essilor Stellest Spectacle Lenshttps://modernod.com/news/essilor-receives-fda-breakthrough-device-designation-for-essilor-stellest-specticle-lens/2479220/Essilor announced that the FDA has granted Breakthrough Device designation to its Essilor Stellest spectacle lens, the company’s new generation lens developed to correct myopia and slow down the progression of myopia in children. The designation of the Essilor’s Stellest spectacle lens as
- Euclid Systems Launches New Euclid MAX Ortho-K Lenshttps://modernod.com/news/euclid-systems-launches-new-euclid-max-ortho-k-lens/2479200/Euclid Systems announced the United States launch of the overnight orthokeratology lens Euclid MAX. Used in children and adult patients with progressive myopia, but especially children, Ortho-K contact lenses gently reshape the cornea to manage myopia while the patient sleeps. “Euclid MAX
- Johnson & Johnson Vision Announces FDA Approval of Acuvue Abiliti Overnight Therapeutic Lenses for Myopia Managementhttps://modernod.com/news/johnson-johnson-vision-announces-fda-approval-of-acuvue-abiliti-overnight-therapeutic-lenses-for-myopia-management/2479199/Johnson & Johnson Vision Care announced that the FDA has approved Acuvue Abiliti-Overnight Therapeutic Lenses. This is the first and only FDA approved orthokeratology (ortho-k) contact lens for the management of myopia. “The FDA approval of Abiliti Overnight marks an
- CooperVision Expands Prescription Options for Biofinity XR Toric Contact Lenseshttps://modernod.com/news/coopervision-expands-prescription-options-for-biofinity-xr-toric-contact-lenses/2479170/CooperVision is introducing a broader range of expanded parameters for its Biofinity XR toric lenses. The addition of sphere powers from ±10.50D to ±20.00D nearly doubles the number of available prescription options specific to this lens, making it easier for eye care professionals to fit patient
- New Alcon Data on Contact Lens, Dry Eye, and Ocular Health to Be Presented at ARVO 2021https://modernod.com/news/new-alcon-data-on-contact-lens-dry-eye-and-ocular-health-to-be-presented-at-arvo-2021/2479151/Alcon will present new data on several of its latest contact lens, dry eye, and ocular health innovations during the Association for Research in Vision and Ophthalmology (ARVO) 2021 virtual meeting taking place May 1-7. Alcon boasts a robust scientific showing at the meeting with nine accepted ab